A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis - Wikidata - wikimedia - TriplyDB

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

http://www.wikidata.org/entity/Q30540674

about

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer Regulation of Metastasis by microRNAs in Ovarian Cancer Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells.Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells.Molecular genetics complexity impeding research progress in breast and ovarian cancers.MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.Functional significance of macrophage-derived exosomes in inflammation and pain The role of microRNAs in ovarian cancer Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.MicroRNAome genome: a treasure for cancer diagnosis and therapy.miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression The Roles of MicroRNAs in Breast Cancer HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.An overview of microRNAs miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation.Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1 Research Progress of MicroRNA in Early Detection of Ovarian Cancer miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.Genetic and molecular changes in ovarian cancer.MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.A chromosome 16p13.11 microduplication causes hyperactivity through dysregulation of miR-484/protocadherin-19 signaling.Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma.Sp1-mediated transcriptional activation of miR-205 promotes radioresistance in esophageal squamous cell carcinoma.miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway.Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.Ovarian cancer: diagnostic, biological and prognostic aspects.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.

P2860

Q26780387-89B1E1A5-F9CF-4DC3-93B3-3CEC9985328F Q26822743-5E3D2A3C-7D1D-4D56-8FF9-421FAB430AF2 Q26997006-14B7939A-97EF-4D0A-AB03-E949F3D0EBED Q27016123-EC4C0BEE-3FC0-4F4A-B549-8DFEAB0DA523 Q28539143-BE0170F5-8741-45B1-9614-24597B7B044B Q30244282-4432325D-FBD0-4088-BEB8-B21C9748C663 Q31029533-E7249939-E9CC-4CE1-B221-FF9F21927536 Q33572313-6C7AC00F-22D3-485B-B7BA-2BFFAB6E25C0 Q33598464-2CA4A466-64E5-4678-A130-EA9980A8CDCB Q33750813-AFDD6CA6-7F17-45A4-8DAE-3285171E97C7 Q33858073-E909D127-7853-49EE-B3B8-7EFB30AEE986 Q33917538-6F9B041F-BCBF-48D9-9C56-5BD0BBF8A463 Q33932873-DCE74AD1-82FB-45B7-B7B3-B3CE066493FF Q34253436-49510C46-975C-483C-9F47-3E9E72A77827 Q34513935-D906C9C3-F330-46BA-9B63-1EB6DF4016E9 Q35123674-5F80A169-971E-49F9-9CE7-240792EB4855 Q35237480-51FFFD27-F845-4F97-9042-B0B2FB3145F1 Q35704188-6F24ACC0-00FF-4B9B-9E27-5EC3285291B6 Q35742473-BF74C539-ED65-45B4-A85C-6631EE9E1FE8 Q35818407-3AF7F343-A3D0-4EEF-AA89-AC2A466C5A09 Q35840631-5886D06A-ACF3-452C-A79A-27CE9A46B231 Q35858483-06202FF3-7547-44AC-99D8-7C09755A1B3C Q36291106-077B828D-74B1-4BC1-858A-A1ED44ED55C0 Q36320168-4FAB06B2-82D6-40E8-91D3-E40F0D7AE207 Q36638558-BB5BA596-E391-44F7-B75E-780EDE6120A7 Q36701651-266DA803-A3CE-461E-A761-5A41098F8822 Q36782334-60D9D91D-A5D2-417E-84ED-A8C10D8CBA3A Q37094076-0B1D22D0-D537-44D6-9597-2E82AB6035FE Q37295716-0C33C400-4B54-4A8B-A7E4-43A98E509464 Q37376531-DB6507D8-514F-4710-B613-9669DD06517B Q37427776-7FB76F5A-03DC-425B-B187-578B7D3C1D48 Q37660908-E3DAA23E-D41E-404A-BDE7-F85C7E3F7FF7 Q37672829-BA4B2A51-2BA3-4221-8919-EA8B24AA2A6F Q37693344-BBB4E510-F26F-4747-B6AF-2E230C65CF5B Q37701470-8FDA5FC4-ADD2-4D87-B273-37935CA4993C Q37734627-313936B0-BDD6-4784-AEAF-EC8578AA7DAB Q37739569-A075BDC5-AB4D-4CF5-86C3-7C99A9DCC5E4 Q38258014-7E973DF5-2803-4BDC-A989-F3024EBD88FB Q38261795-23FCC0E1-961B-4B68-9352-631D562B98A4 Q38366731-71464AC7-08B4-4463-BF11-9C9E379C7974

P2860

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

http://www.wikidata.org/entity/Q30540674

description

2013 nî lūn-bûn

@nan

2013 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A microRNA signature defines c ...... ugh modulation of angiogenesis

@ast

A microRNA signature defines c ...... ugh modulation of angiogenesis

@en

type

label

A microRNA signature defines c ...... ugh modulation of angiogenesis

@ast

A microRNA signature defines c ...... ugh modulation of angiogenesis

@en

prefLabel

A microRNA signature defines c ...... ugh modulation of angiogenesis

@ast

A microRNA signature defines c ...... ugh modulation of angiogenesis

@en

P1433

Q30540674-B7E8E818-797F-4E74-ABF9-D2417DE164BB

P1476

Q30540674-9B2FCB01-5990-45E1-99EB-24A257271164

P2093

Q30540674-1CEF68A5-E89E-400A-8EDD-FE89A90FD2DE

Q30540674-1E5358F3-105C-41A7-91D1-D795D87A238B

Q30540674-238E148E-BBAE-45BE-8106-D2B594D66141

Q30540674-547CB126-41D9-41BF-ABB7-5D085FC515F9

Q30540674-7EC5EEFF-F2CE-4CE9-ABF0-F3D0885B9ECF

Q30540674-CA0A3250-207F-4683-81BE-4D2977B0CB0B

Q30540674-DD62D019-257B-462B-97D1-C59E42EB9AB7

Q30540674-E617BB65-AABE-421E-B7A8-3E51018958B6

Q30540674-EC10EA77-1580-4AFC-8D4B-6E093D926A19

Q30540674-F2FADE58-47B7-4207-8CD8-D04517C26250

P2860

Q30540674-011F958C-4876-4B00-B5DA-A41A131A6A6E

Q30540674-050F5C15-6215-4604-9404-E9B2609B897C

Q30540674-0D906B42-0B34-4FF6-A9E5-19C487C80925

Q30540674-1BC830C6-E2D7-4819-A18B-55445B52A60D

Q30540674-1EBEA626-81ED-4E52-8422-D224DC4AA0AF

Q30540674-363AB283-0AED-496E-8E20-951BA59F583D

Q30540674-3C169C15-14AA-4672-9AA0-1911D8D258F2

Q30540674-3C44FC0B-0075-47DE-8B54-5F996ED9DAC5

Q30540674-406ADB18-DDC5-431D-98E8-16E54351F774

Q30540674-44F79261-1FD8-483A-BDEB-261B1B8BB403

P304

Q30540674-EC9A87B9-E1A4-4199-8D75-E3201096FE91

P31

Q30540674-AC43E2DE-3E98-40A0-A704-A5EF830E5E4D

P356

Q30540674-A48237DB-4CF7-4868-B54E-0CA2CBCFE8FB

P407

Q30540674-888D329B-FFEB-4E07-80F4-0D92D9D013E0

P433

Q30540674-FB484733-38F1-4FC9-8635-883D09C2DCB3

P478

Q30540674-580AC0A7-D241-411A-879A-B1D74CB72AF0

P50

Q30540674-08FE8B98-5C53-479E-82EB-5DC0355B53A9

Q30540674-4015CA9C-FDAB-4F61-A74D-E1C3ED08A0D8

Q30540674-6E6440E4-401F-4DB8-8872-BB65AE88EE1E

Q30540674-72F0BA4A-4E27-44FF-BDDF-AB2FE072745A

Q30540674-B0D0FCAF-4E3E-4979-9912-90D96780F216

Q30540674-BB6FDBE5-56A8-48C9-A2D4-C407566BA43D

Q30540674-BFFC3BBA-4C7C-484B-9B16-C8D22A160D87

Q30540674-E09F68F3-9E4C-4067-9DB8-BA4A7E17C201

Q30540674-E4EB1573-5F3E-4324-AEFD-B68452B03D99

P577

Q30540674-392C9A14-B397-41EE-8397-965C50B5038C

P5875

Q30540674-005B1C55-21F9-4537-8036-080EF72775EA

P698

Q30540674-C2E11ED1-FCC2-447A-AB79-5FD115FEE285

P921

Q30540674-29CD8D92-E7F1-4550-B654-8EEAD6B5E73A

Q30540674-2D6D472D-ACF8-4CDE-A704-81E1E02E779C

P932

Q30540674-193E858C-A3B1-4E0A-9062-0B15B74531F5

P356

PNAS.1305472110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A microRNA signature defines c ...... ugh modulation of angiogenesis

@en

P2093

Dorothee Wernicke

http://www.w3.org/2001/XMLSchema#string

Elisa Concetta Onesti

http://www.w3.org/2001/XMLSchema#string

Francesca Lovat

http://www.w3.org/2001/XMLSchema#string

Gennaro Chiappetta

http://www.w3.org/2001/XMLSchema#string

Hansjuerg Alder

http://www.w3.org/2001/XMLSchema#string

Patrizia Pellegrini

http://www.w3.org/2001/XMLSchema#string

Roberto Cirombella

http://www.w3.org/2001/XMLSchema#string

Roberto Sorio

http://www.w3.org/2001/XMLSchema#string

Simona Giglio

http://www.w3.org/2001/XMLSchema#string

Simona Losito

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

A microRNA expression signature of human solid tumors defines cancer gene targets

Modes of resistance to anti-angiogenic therapy

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

Cancer statistics, 2008

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNA expression profiles classify human cancers

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Analyzing real-time PCR data by the comparative C(T) method

P304

9845-9850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1305472110

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Volinia

Gustavo Baldassarre

Andrea Vecchione

Barbara Belletti

Antonella Stoppacciaro

Carlo Maria Croce

P577

2013-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236931311

http://www.w3.org/2001/XMLSchema#string

P698

23697367

http://www.w3.org/2001/XMLSchema#string

P921

P932

3683704

http://www.w3.org/2001/XMLSchema#string